Point72 Asset Management’s Sage Therapeutics SAGE Stock Holding History

Point72 Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-79	Closed	-$627	–	2554
2025 Q1	$627	Buy	+79	New	+$578	﹤0.01%	1983
2024 Q3	–	Sell	-6,200	Closed	-$67.3K	–	2299
2024 Q2	$67.3K	Sell	6,200 -635,011	-99%	-$8.14M	﹤0.01%	1738
2024 Q1	$12M	Buy	+641,211	New	+$14.8M	0.03%	649
2023 Q4	–	Sell	-110,000	Closed	-$2.26M	–	2730
2023 Q3	$2.26M	Buy	+110,000	New	+$3.18M	0.01%	1109
2022 Q4	–	Sell	-801,600	Closed	-$31.4M	–	1759
2022 Q3	$31.4M	Sell	801,600 -457,700	-36%	-$17.7M	0.13%	214
2022 Q2	$40.7M	Buy	1,259,300 +818,300	+186%	+$27.4M	0.17%	161
2022 Q1	$14.6M	Buy	441,000 +104,100	+31%	+$3.91M	0.06%	410
2021 Q4	$14.3M	Sell	336,900 -420,500	-56%	-$17.6M	0.06%	414
2021 Q3	$33.6M	Buy	757,400 +529,200	+232%	+$24.3M	0.15%	179
2021 Q2	$13M	Sell	228,200 -105,500	-32%	-$7.46M	0.06%	386
2021 Q1	$25M	Buy	+333,700	New	+$27.4M	0.12%	220
2020 Q4	–	Sell	-302,214	Closed	-$18.5M	–	1105
2020 Q3	$18.5M	Buy	302,214 +179,080	+145%	+$9.08M	0.09%	289
2020 Q2	$5.12M	Buy	+123,134	New	+$4.47M	0.03%	475
2019 Q1	–	Sell	-256,459	Closed	-$24.6M	–	1207
2018 Q4	$24.6M	Buy	256,459 +81,459	+47%	+$9.32M	0.12%	218
2018 Q3	$24.7M	Buy	175,000 +35,000	+25%	+$5.4M	0.1%	248
2018 Q2	$21.9M	Buy	140,000 +37,400	+36%	+$5.87M	0.09%	279
2018 Q1	$16.5M	Buy	102,600 +92,600	+926%	+$15.7M	0.07%	326
2017 Q4	$1.65M	Sell	10,000 -168,350	-94%	-$16.3M	0.01%	760
2017 Q3	$11.1M	Buy	178,350 +53,350	+43%	+$4.19M	0.05%	380
2017 Q2	$9.96M	Sell	125,000 -270,300	-68%	-$19.5M	0.06%	388
2017 Q1	$28.1M	Buy	395,300 +330,800	+513%	+$19.4M	0.16%	179
2016 Q4	$3.29M	Sell	64,500 -102,100	-61%	-$4.81M	0.02%	497
2016 Q3	$7.67M	Sell	166,600 -1,100	-0.7%	-$44.8K	0.05%	327
2016 Q2	$5.05M	Buy	+167,700	New	+$5.59M	0.03%	424